India approves emergency use of remdesivir to treat Covid-19 patients

Remdesivir is the first drug to show improvement in Covid-19 patients in formal clinical trials. It was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators.